FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894703695> ?p ?o ?g. }

• W2894703695 endingPage "864" @default.
• W2894703695 startingPage "858" @default.
• W2894703695 abstract "Chronic myeloid leukemia (CML) responds well to BCR-ABL tyrosine kinase inhibitors (TKI), such as imatinib and dasatinib. However, these inhibitors have been less effective as single agents in the blast phase-CML. In this work, we show that anisomycin, a clinically available drug, targets CML cells at all stages of development and enhances BCR-ABL TKIs’ efficacy. Anisomycin at nanomolar concentration inhibits proliferation and induces apoptosis in a panel of CML cell lines in a dose-dependent manner. It induces apoptosis CD34 stem/progenitor cells isolated from patients with blast phase CML. Using colony formation and serial replating assays, we further show that anisomycin inhibits CML CD34 cell differentiation, proliferation and self-renewal. Additionally, anisomycin is less effective in normal bone marrow (NBM) CD34 cells, suggesting the selective anti-leukemia activity of anisomycin. Combination of anisomycin with imatinib or dasatinib achieves significantly better efficacy than TKI alone in leukemia cell lines and patient samples while sparing normal counterparts. Mechanistically, we demonstrate that p38 MAPK/JNK activation is not required for anti-leukemia activities of anisomycin. Instead, anisomycin displays preferential inhibitory effects to Wnt/β-catenin-mediated signaling in CML. Our work provides the preclinical evidence on the potent efficacy of anisomycin in leukemia and its mechanisms of action. Our work suggests that anisomycin is a potential drug to overcome resistance to BCR-ABL TKI treatment in blast phase CML." @default.
• W2894703695 created "2018-10-12" @default.
• W2894703695 creator A5019786135 @default.
• W2894703695 creator A5068014633 @default.
• W2894703695 creator A5078453098 @default.
• W2894703695 creator A5085633250 @default.
• W2894703695 date "2018-11-01" @default.
• W2894703695 modified "2023-09-27" @default.
• W2894703695 title "Antibiotic anisomycin selectively targets leukemia cell lines and patient samples through suppressing Wnt/β-catenin signaling" @default.
• W2894703695 cites W1489055368 @default.
• W2894703695 cites W1776173334 @default.
• W2894703695 cites W1969717239 @default.
• W2894703695 cites W2006160098 @default.
• W2894703695 cites W2006917576 @default.
• W2894703695 cites W2012962381 @default.
• W2894703695 cites W2015519364 @default.
• W2894703695 cites W2023594205 @default.
• W2894703695 cites W2028556558 @default.
• W2894703695 cites W2031216046 @default.
• W2894703695 cites W2043332526 @default.
• W2894703695 cites W2057581154 @default.
• W2894703695 cites W2096882254 @default.
• W2894703695 cites W2109555166 @default.
• W2894703695 cites W2118566262 @default.
• W2894703695 cites W2119910663 @default.
• W2894703695 cites W2122224021 @default.
• W2894703695 cites W2133106648 @default.
• W2894703695 cites W2149468947 @default.
• W2894703695 cites W2154875930 @default.
• W2894703695 cites W2160851769 @default.
• W2894703695 cites W2166654361 @default.
• W2894703695 cites W2166920557 @default.
• W2894703695 cites W2261445477 @default.
• W2894703695 cites W2335708887 @default.
• W2894703695 cites W2461250649 @default.
• W2894703695 cites W2478478604 @default.
• W2894703695 cites W2552576310 @default.
• W2894703695 cites W2769846497 @default.
• W2894703695 doi "https://doi.org/10.1016/j.bbrc.2018.09.183" @default.
• W2894703695 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30301525" @default.
• W2894703695 hasPublicationYear "2018" @default.
• W2894703695 type Work @default.
• W2894703695 sameAs 2894703695 @default.
• W2894703695 citedByCount "17" @default.
• W2894703695 countsByYear W28947036952019 @default.
• W2894703695 countsByYear W28947036952020 @default.
• W2894703695 countsByYear W28947036952021 @default.
• W2894703695 countsByYear W28947036952022 @default.
• W2894703695 countsByYear W28947036952023 @default.
• W2894703695 crossrefType "journal-article" @default.
• W2894703695 hasAuthorship W2894703695A5019786135 @default.
• W2894703695 hasAuthorship W2894703695A5068014633 @default.
• W2894703695 hasAuthorship W2894703695A5078453098 @default.
• W2894703695 hasAuthorship W2894703695A5085633250 @default.
• W2894703695 hasConcept C109159458 @default.
• W2894703695 hasConcept C171122931 @default.
• W2894703695 hasConcept C184235292 @default.
• W2894703695 hasConcept C201750760 @default.
• W2894703695 hasConcept C203014093 @default.
• W2894703695 hasConcept C2777413986 @default.
• W2894703695 hasConcept C2777583451 @default.
• W2894703695 hasConcept C2778073123 @default.
• W2894703695 hasConcept C2778461978 @default.
• W2894703695 hasConcept C2778729363 @default.
• W2894703695 hasConcept C2779536868 @default.
• W2894703695 hasConcept C28328180 @default.
• W2894703695 hasConcept C502942594 @default.
• W2894703695 hasConcept C71924100 @default.
• W2894703695 hasConcept C86803240 @default.
• W2894703695 hasConcept C95444343 @default.
• W2894703695 hasConcept C98274493 @default.
• W2894703695 hasConceptScore W2894703695C109159458 @default.
• W2894703695 hasConceptScore W2894703695C171122931 @default.
• W2894703695 hasConceptScore W2894703695C184235292 @default.
• W2894703695 hasConceptScore W2894703695C201750760 @default.
• W2894703695 hasConceptScore W2894703695C203014093 @default.
• W2894703695 hasConceptScore W2894703695C2777413986 @default.
• W2894703695 hasConceptScore W2894703695C2777583451 @default.
• W2894703695 hasConceptScore W2894703695C2778073123 @default.
• W2894703695 hasConceptScore W2894703695C2778461978 @default.
• W2894703695 hasConceptScore W2894703695C2778729363 @default.
• W2894703695 hasConceptScore W2894703695C2779536868 @default.
• W2894703695 hasConceptScore W2894703695C28328180 @default.
• W2894703695 hasConceptScore W2894703695C502942594 @default.
• W2894703695 hasConceptScore W2894703695C71924100 @default.
• W2894703695 hasConceptScore W2894703695C86803240 @default.
• W2894703695 hasConceptScore W2894703695C95444343 @default.
• W2894703695 hasConceptScore W2894703695C98274493 @default.
• W2894703695 hasFunder F4320321001 @default.
• W2894703695 hasIssue "3" @default.
• W2894703695 hasLocation W28947036951 @default.
• W2894703695 hasLocation W28947036952 @default.
• W2894703695 hasOpenAccess W2894703695 @default.
• W2894703695 hasPrimaryLocation W28947036951 @default.
• W2894703695 hasRelatedWork W2055551175 @default.
• W2894703695 hasRelatedWork W2060584185 @default.
• W2894703695 hasRelatedWork W2061493553 @default.
• W2894703695 hasRelatedWork W2080418768 @default.

• next